Novel therapies show efficacy in Fabry's disease

By  

Inpharma, Vol. 1, Iss. 1296, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Phosphodiesterase V inhibitors show efficacy in ED

By  

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of 24 Weeks of Therapy with Bendroflumethiazide 1.25 mg/day or 2.5 mg/day and Potassium Chloride Compared with Enalapril 10 mg/day and Amlodipine 5 mg/day in Patients with Mild to Moderate Primary Hypertension: A Multicentre, Randomised, Open Study

By Rasmussen S.  

Clinical Drug Investigation, Vol. 26, Iss. 2, 2006-01 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite

Safety and efficacy of rotigotine transdermal patch in patients with restless legs syndrome: a post-hoc analysis of patients taking 1 – 3 mg/24 h for up to 5 years

By Dohin Elisabeth   Högl Birgit   Ferini-Strambi Luigi   Schollmayer Erwin   Fichtner Andreas   Bauer Lars   García-Borreguero Diego  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 15-25

Informa Healthcare

Access to resources Recommend Favorite

For patients with hepatitis C virus (HCV) infection who respond rapidly to peginterferon-α-2a, 8 weeks of therapy is as effective as a 24 weeks

By  

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite